GET A VALUABLE CERTIFICATE FOR JOB MARKET


ACADEMIC RECOGNITION OF 3 OR 6 CREDITS


DESIGNED FOR EXPERTS BY EXPERTS


INTRODUCTION TO BENEFIT-RISK ASSESSMENT AND PHARMACOECONOMICS IN DECISION MAKING


Eu2P Certificate: Introduction to benefit-risk assessment and pharmacoeconomics in decision making

OBJECTIVES

The objective of the module is to gain insight in the role of benefit-risk assessment and pharmacoeconomics in the process of decision-making on medicines by different stakeholders.

At the end of this module, you will be able to:

delineate the process of decision-making and the perspectives of the stakeholders involved

explain the rationale of benefit-risk assessment and pharmacoeconomic evaluation

evaluate the methodology and results of benefit-risk and pharmaco-economic studies

translate of the results into the process of decision-making

Benefit-risk assessment, decision making, pharmacoeconomics, communication

 

MODULE PARTS

  1. Introduction
  2. Benefits
  3. Risk/Harms
  4. Principles and methods of comparative benefit-risk assessment
  5. Principles of Pharmacoeconomics

 

TRAINER TEAM

Coordinator: Dr Shahab Abtahi (from Universiteit Utrecht)

Expert(s): Prof Olaf Klungel, Dr Rob Heerdink, Olivia Lewis, Dr Christine Leopold, Elizabeth Comberg (from Universiteit Utrecht).

Introductory level
75 h workload over 3 months (3 ECTS credits)
Key dates
Course calendar
Certificate award
or included in Master Year 2 programme
English language
Online based learning
Student : 1,500 €
Professional : 3,000 €
  Savings could be offered under eligibility conditions.

Applications currently closed

Application to this training will be available
from January 27th, 2025 to September 07th, 2025.
Thanks for applying during this period.

Contact the Eu2P Central Office

Applications will open on January 27th, 2025. Please contact the Eu2P Central Office for information.

Or include this module in your training curriculum choices...

Master Year 2 PhD



Confused? Read the FAQs...

NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Powered By

Eu2P Executive Board partners

Created By

Eu2P project consortium partners